Stage Ia-IIa cancer of the cervix

Cancer J. 2003 Sep-Oct;9(5):395-403. doi: 10.1097/00130404-200309000-00010.

Abstract

Early-stage cervical cancer is unique among malignancies in that two radically different yet equally efficacious treatments can be offered to most patients with the disease. The choice between surgery and radiation therapy depends on the patient's age and comorbidities, tumor factors, physician bias, and discussion of the risks and benefits of each modality. A thorough discussion between the physician and patient is necessary to determine the optimal management for each individual. This review discusses the major factors that influence physician and patient management choices.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Decision Making*
  • Female
  • Humans
  • Neoplasm Staging
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / therapy*